Stryker Corp., US8636671013

Stryker Corp. stock results on October 29, 2026, pre-market little changed

Published on 10/26/2026 at 07:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The medical-device company operates across 2 divisions. At Lang & Schwarz the stock trades pre-market at EUR 275.60 on October 26, 2026, +0.18 percent above the Xetra close of October 23, 2026.

Upcoming Results And Trading

  • Stryker is scheduled to report quarterly results on October 29, 2026.
  • Stryker operates through 2 divisions spanning orthopedic implants, MedSurg and Neurotechnology products.
  • Stryker Corp. stock trades pre-market at EUR 275.60 at 7:33 a.m. CET at Lang & Schwarz on October 26, 2026, +0.18 percent above the Xetra close of October 23, 2026.
Flatlay-Arrangement mit Aktienzertifikat und ISIN-Karte US8636671013 illustriert eine Investition in Stryker Corp. Medizintechnik-Aktien, Illustration mit AI erstellt.

Stryker's next quarterly results are scheduled for October 29, 2026, after the market closes, according to Benzinga. Stryker Corp. stock trades pre-market at EUR 275.60 at 7:33 a.m. CET at Lang & Schwarz on October 26, 2026, +0.18 percent above the Xetra close of October 23, 2026 (EUR 275.10).

Quarterly results ahead

The October 29, 2026 release is the next scheduled quarterly reporting date for Stryker. Benzinga lists the earnings release after the market close and a conference call at 4:30 p.m. that day.

Ahead of the Xetra open

The stock is EUR 0.50 above the Xetra close in the pre-market session. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Stryker stock.

How Stryker makes money

Stryker operates through 2 divisions: Orthopaedics and Spine, and MedSurg and Neurotechnology. Its products include implants, surgical equipment, navigation systems, patient-handling devices and neurotechnology products sold to medical professionals, hospitals and healthcare institutions. Market context: Market report S&P 500.

More news and analysis on Stryker stock

Disclaimer...
en | US8636671013 | STRYKER CORP. | boerse | 70411833 | bgmi